DevelRx offers expert advice and support for early-stage discovery projects seeking new treatments for drug addiction, psychiatric and neurological disorders, obesity and binge-eating disorder. All aspects of strategy, screening and project support management are performed. Services include early-stage abuse and dependence liability assessments to de-risk programs.
We can help navigate the complex challenges faced during drug development. Our consultants are globally-acknowledged experts in assessment of abuse potential and dependence of centrally-acting drugs. Our services to evaluate and predict the abuse potential risk of new drugs include 8-factor analyses, briefing documents to support non-clinical abuse testing programs and abuse potential assessment waiver submissions
With extensive experience of drug registration procedures, we can help to bring drugs into clinical development and onto the market. We have provided key pre-clinical support for 16 drug registrations including in the therapeutic areas of ADHD, binge-eating disorder, schizophrenia, substance abuse, Parkinson’s disease, migraine, epilepsy and obesity
DevelRx are world experts on market positioning and drug lifecycle management of centrally-acting drugs. We perform strategic reviews of therapeutic indications including market opportunities, barriers to market entry and likelihood of success. Our services include evaluation of licencing opportunities, due diligence reviews and medical training of scientists and clinicians